glp-1-directed nmda receptor antagonism for obesity treatment GLP1 Agonists—Effects beyond and Diabetes Frontiers | The agony and
Description
Tirzepatide delivered 20.2% body weight reduction versus 13.7% for semaglutide
PMID 35985340
[3] Avoid foods high in empty calories, such as overly processed foods, which can make you feel full without providing micronutrient support
Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy
10.1016/j.jacc.2008.10.033
Am J Respir Crit Care Med 165(9):12171239
